GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jul 8, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 8, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, transaction-in-own-shares, sec-filing
Related Tickers: GSK
TL;DR
GSK is buying back its own stock via Merrill Lynch.
AI Summary
GSK plc announced on July 8, 2025, that it purchased a number of its own ordinary shares through its corporate stockbroker, Merrill Lynch International. The filing does not specify the exact number of shares or the total dollar amount involved in these transactions.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This is a routine disclosure of share repurchases, which is common for publicly traded companies.
Key Players & Entities
- GSK plc (company) — The company making the announcement and repurchasing shares.
- Merrill Lynch International (company) — The corporate stockbroker acting on behalf of GSK plc for the share purchases.
- July 8, 2025 (date) — The date of the announcement and the transactions.
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K filing is a report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, specifically reporting a transaction in its own shares.
Who is acting as GSK plc's corporate stockbroker for these transactions?
Merrill Lynch International is acting as GSK plc's corporate stockbroker for these transactions.
On what date did GSK plc announce these share purchases?
GSK plc announced these share purchases on July 8, 2025.
What type of shares did GSK plc purchase?
GSK plc purchased its own ordinary shares of 31¼ pence each.
Does the filing specify the number of shares purchased or the total amount spent?
No, the filing states that GSK plc has purchased a 'number of the Company's ordinary shares' but does not specify the exact quantity or the total dollar amount.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 8, 2025 regarding GSK plc (GLAXF).